TabCAT Publications

Peer-reviewed Publications

  1. Tsoy E, La Joie R, VandeVrede L, Rojas JC, Yballa C, Chan B, Lago AL, Rodriguez AM, Goode CA, Erlhoff SJ, Tee BL, Windon C, Lanata S, Kramer JH, Miller BL, Dilworth-Anderson P, Boxer AL, Rabinovici GD, Possin KL. Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias. Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13686.

  2. Gianina T, Lorena S, Dilaxy K, Patrick C, Florian K, Thomas M, Ursi K, Andreas UM, Kate P, Rankin KP, Felbecker A. The German version of the tablet-based UCSF Brain Health Assessment is sensitive to early symptoms of neurodegenerative disorders. Brain Behav. 2023:e3329. doi: 10.1002/brb3.3329.

  3. Thompson LI, Kunicki ZJ, Emrani S, Strenger J, De Vito AN, Britton KJ, Dion C, Harrington KD, Roque N, Salloway S, Sliwinski MJ, Correia S, Jones RN. Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults. Alzheimers Dement (Amst). 2023;15(4):e12500. doi: 10.1002/dad2.12500.

  4. Gajardo-Vidal A, Montembeault M, Lorca-Puls DL, Licata AE, Bogley R, Erlhoff SJ, Ratnasiri B, Ezzes Z, Battistella G, Tsoy E, Watson Pereira C, DeLeon J, Tee BL, Henry ML, Miller ZA, Rankin KP, Mandelli ML, Possin KL, Gorno-Tempini ML. Assessing processing speed and its neural correlates in the three variants of primary progressive aphasia with a non-verbal tablet-based task. Cortex. 2023. doi: doi.org/10.1016/j.cortex.2023.10.011.
  5. Barreto Chang OL, Whitlock EL, Arias AD, Tsoy E, Allen IE, Hellman J, Bickler PE, Miller B, Possin KL. A novel approach for the detection of cognitive impairment and delirium risk in older patients undergoing spine surgery. J Am Geriatr Soc. 2022 Sep 20. doi: 10.1111/jgs.18033.
  6. Mullady SS, Castellanos S, Lopez L, Aguirre G, Weeks J, King S, Valle K, Goode C, Tsoy E, Possin K, Miller B, Kushel M, Lanata S. Neurocognitive health of older adults experiencing homelessness in Oakland, California. Front Neurol. 2022 Jul 22;13:905779. doi: 10.3389/fneur.2022.905779. 
  7. Sideman AB, Chalmer R, Ayers E, Gershon R, Verghese J, Wolf M, Ansari A, Arvanitis M, Bui N, Chen P, Chodos A, Corriveau R, Curtis L, Ehrlich AR, Farias SET, Goode C, Hill-Sakurai L, Nowinski CJ, Premkumar M, Rankin KP, Ritchie CS, Tsoy E, Weiss E, Possin KL. Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care. J Alzheimers Dis. 2022 Jan 31. doi: 10.3233/JAD-215106.
  8. Iliadou P, Bakirtzis C, Ioannidis P, Possin KL, Zygouris S, Sintila SA, Grigoriadis N, Aretouli E. Neuropsychological correlates of cerebellar volumes in multiple sclerosis: an MRI volumetric analysis study. J. Integr. Neurosci. 2022;21:013. doi: 10.31083/j.jin2101013.
  9. Tsoy E, Zygouris S, Possin KL. Current State of Self-Administered Brief Computerized Cognitive Assessments for Detection of Cognitive Disorders in Older Adults: A Systematic Review. J Prev Alzheimers Dis. 2021;8:267-276. doi: 10.14283/jpad.2021.11.
  10. Ray SK, Manz SN. Brain health assessment in macular degeneration patients undergoing intravitreal anti-vascular endothelial growth factor injections (the BHAM study): An interim analysis. Retina. 2021;41:1748-1753. doi: 10.1097/IAE.0000000000003066.
  11. Rodríguez-Salgado AM, Llibre-Guerra JJ, Tsoy E, Peñalver-Guia AI, Bringas G, Erlhoff SJ, Kramer JH, Allen IE, Valcour V, Miller BL, Llibre-Rodríguez JJ, Possin KL. A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults. J Alzheimers Dis. 2021;79:85-94. doi: 10.3233/JAD-200985.
  12. Tsoy E, Strom A, Iaccarino L, Erlhoff SJ, Goode CA, Rodriguez AM, Rabinovici GD, Miller BL, Kramer JH, Rankin KP, La Joie R, Possin KL. Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET. Alzheimers Res Ther. 2021;13:36. doi: 10.1186/s13195-021-00776-w
  13. Staffaroni AM, Tsoy E, Taylor J, Boxer AL, Possin KL. Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinics. Pract Neurol (Fort Wash Pa). 2020;2020:24-45.
  14. Tsoy E, Possin KL, Thompson N, Patel K, Garrigues SK, Maravilla I, Erlhoff SJ, Ritchie CS. Self-administered cognitive testing by older adults at-risk for cognitive decline. J Prev Alz Dis. 2020;7:283-287. doi: 10.14283/jpad.2020.25.
  15. Tsoy E, Erlhoff SJ, Goode CA, Dorsman KA, Kanjanapong S, Lindbergh CA, La Joie R, Strom A, Rabinovici GD, Lanata SC, Miller BL, Tomaszewski Farias SE, Kramer JH, Rankin KP, Possin KL. BHA-CS: a novel cognitive composite for preclinical and prodromal Alzheimer’s disease. Alzheimer’s Dement. 2020;12:e12042. doi: 10.1002/dad2.12042.
  16. Alioto AG, Mumford P, Wolf A, Casaletto KB, Erlhoff S, Moskowitz T, Kramer JH, Rankin KP, Possin KL. White matter correlates of cognitive performance on the UCSF Brain Health Assessment. J Int Neuropsychol Soc. 2019;25:654-658. doi: 10.1017/S1355617719000225.
  17. Possin KL, Moskowitz T, Erlhoff SJ, Rogers KM, Johnson ET, Steele NZR, Higgins JJ, Stiver J, Alioto AG, Farias ST, Miller BL, Rankin KP. The Brain Health Assessment for detecting and diagnosing neurocognitive disorders. J Am Geriatr Soc. 2018;66:150-156. doi: 10.1111/jgs.15208.

Presentations and Posters

  1. Tsoy E, Erlhoff SJ, Kanjanapong S, Casaletto KB, Rankin KP, Kramer JH, Possin KL. Reliable change in older adults on a brief computerized cognitive test: comparisons with the MoCA and associations with the amyloid burden. Presented at the 2019 Alzheimer’s Association International Conference, Los Angeles, CA.
  2. Kanjanapong S, Altendahl M, Tsoy E, Erlhoff SJ, Brown EG, Rosen HJ, Ostrem JL, Lieu K, Nguyen V, Rankin KP, Kramer JH, Possin KL. The TabCAT Brain Health Assessment quickly and accurately detects level II mild cognitive impairment in Parkinson’s Disease by MDS Task Force criteria. Presented at the 2019 Alzheimer’s Association International Conference, Los Angeles, CA.
  3. Erlhoff SJ, Rankin KP, Kramer JH, Possin KP. The UCSF Brain Health Assessment Favorites memory test: delayed free recall and recognition have highly similar neuroanatomical substrates. Presented at the 2019 International Neuropsychological Society Conference, New York, NY.
  4. Alioto AG, Erlhoff SJ, Casaletto KB, Mumford P, Kramer JH, Rankin KP, Possin KL. White matter correlates of the UCSF Brain Health Assessment. Presented at the 2018 International Neuropsychological Society Conference, Washington, DC.
  5. Dorsman KA, Erlhoff SJ, Lanata SC, Farias SE, Kramer JH, Rankin KP, Possin KL. The UCSF Brain Health Assessment: a culturally appropriate and sensitive screening tool to detect cognitive impairment in Spanish speakers. Presented at the 2018 Latinos and Alzheimer’s Disease, Puerto Rico.
  6. Alioto AG, Moskowitz T, Erlhoff SJ, Bott NT, Rankin KP, Kramer JH, Possin KL. Neuroanatomical correlates of the TabCAT Match test. Presented at the 2017 International Neuropsychological Society Conference, New Orleans, LA.
  7. Mead C, Erlhoff SJ, Moskowitz T, Alioto AG, Saloner R, Rankin KP, Possin KL. Validation of the TabCAT Favorites memory test: neuroanatomical correlates in older adults. Presented at the 2017 International Neuropsychological Society Conference, New Orleans, LA.
  8. Possin KL, Moskowitz T, Erlhoff SJ, Rankin KP. The TabCAT Brain Health Assessment: a highly efficient and sensitive approach to detecting very mild cognitive impairment. Presented at the 2017 International Neuropsychological Society Conference, New Orleans, LA.
  9. Possin KL, Moskowitz T, Erlhoff SJ, Stiver J, Rogers K, Pressman P, Rankin KP, Kramer JH. The TabCAT Brain Health Assessment quickly and accurately detects level 2 mild cognitive impairment in Parkinson’s disease. Presented at the 2017 Alzheimer’s Association International Conference, London, UK.
  10. Possin KL, Thompson N, Patel K, Garrigues SK, Maravilla I, Moskowitz T, Erlhoff SJ, Rankin KP, Kramer JH, Ritchie CS. The feasibility and reliability of at-home tablet-based cognitive testing in an elderly cohort at-risk for cognitive decline. Presented at the 2017 Alzheimer’s Association International Conference, London, UK.